Detalles de la búsqueda
1.
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.
Cancer
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38752572
2.
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.
BMC Cancer
; 24(1): 735, 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38879498
3.
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
JAMA
; 331(1): 49-59, 2024 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059899
4.
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients.
Int J Mol Sci
; 25(5)2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473737
5.
Healthcare Professional Communication on Sexual Health: A Report from the Italian Working Group on Adolescents and Young Adults with Cancer.
Oncologist
; 28(10): e884-e890, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37348061
6.
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group.
Curr Oncol Rep
; 24(7): 843-860, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320498
7.
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review.
Int J Mol Sci
; 23(13)2022 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35806079
8.
BRCA mutation carriers' perception about benefits and risks associated with combined hormonal contraceptives use.
Eur J Contracept Reprod Health Care
; 27(6): 439-444, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35946412
9.
BRCA mutation carriers' perceptions on postmenopausal hormone therapy: An Italian study.
Psychooncology
; 30(10): 1711-1719, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34002428
10.
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials.
BMC Cancer
; 20(1): 418, 2020 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32404154
11.
Breast ultrasonography (BU) in the screening protocol for women at hereditary-familial risk of breast cancer: has the time come to rethink the role of BU according to different risk categories?
Int J Cancer
; 144(5): 1001-1009, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30098212
12.
Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
Gynecol Oncol
; 154(1): 163-168, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31104904
13.
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.
Oncology
; 93(6): 377-386, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28848147
14.
Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
Int J Mol Sci
; 18(1)2017 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28054957
15.
Molecular characterization and targeted therapeutic approaches in breast cancer.
Breast Cancer Res
; 17: 60, 2015 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25902832
16.
Breast cancer screening of mutation carriers in the era of COVID-19 pandemic.
Int J Cancer
; 147(12): 3574-3575, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32557656
17.
Twenty-years experience with de novo metastatic breast cancer.
Int J Cancer
; 137(6): 1417-26, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25736070
18.
Male bilateral risk-reducing mastectomy: Report of a case.
Breast J
; 26(10): 2135-2136, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519448
19.
Combined hormonal contraceptives in BRCA gene mutation carriers: why not?
Eur J Contracept Reprod Health Care
; 24(6): 417-419, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31361161
20.
Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer.
Cancer Treat Rev
; 126: 102723, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555857